SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-22-073028
Filing Date
2022-06-21
Accepted
2022-06-21 17:02:11
Documents
2
Group Members
HEIDI S. SHIPPELL-HEILAND 2008 IRREVOCABLE TRUSTMICHAEL TOROK

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2218945d1_sc13d.htm SC 13D 99245
2 EXHIBIT 99.1 tm2218945d1_ex99-1.htm EX-99.1 6752
  Complete submission text file 0001104659-22-073028.txt   107606
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 221028871
SIC: 2834 Pharmaceutical Preparations

Mailing Address 68 MAZZEO DRIVE RANDOLPH MA 02368
Business Address 68 MAZZEO DRIVE RANDOLPH MA 02368 617-680-6709
JEC II Associates, LLC (Filed by) CIK: 0001477326 (see all company filings)

IRS No.: 262258828 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D